MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor
- PMID: 10048588
- DOI: 10.1002/(SICI)1097-4652(199902)178:2<235::AID-JCP13>3.0.CO;2-S
MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor
Abstract
Although the significance of vascular endothelial growth factor (VEGF) and its receptors in angiogenesis is well established, the signal transduction cascades activated by VEGF and their involvement in mediating the mitogenic response of endothelial cells to VEGF are incompletely characterized. Here we demonstrate that VEGF activates mitogen-activated protein (MAP) kinases, including the extracellular signal-regulated protein kinase (ERK) and p38 MAP kinase, phosphatidylinositol 3-kinase (PI 3-kinase), and p70 S6 kinase in human umbilical vein endothelial cells (HUVEC). The activation of these enzymes was assayed by kinase phosphorylation and by kinase activity towards substrates. Studies with PI 3-kinase inhibitors revealed that activation of p70 S6 kinase was mediated by PI 3-kinase. Selective inhibition of ERK, PI 3-kinase, and p70 S6 kinase with the inhibitors PD098059, LY294002, and rapamycin, respectively, inhibited VEGF-stimulated HUVEC proliferation. In marked contrast, the p38 MAP kinase inhibitor SB203580 not only failed to inhibit but actually enhanced HUVEC proliferation; this effect was associated with the phosphorylation of Rb protein. Rb phosphorylation resulted from a decrease in the level of the cdk inhibitor p27KiP1. These results indicate that the activities of ERK, PI 3-kinase, and p70 S6 kinase are essential for VEGF-induced HUVEC proliferation. p38 MAP kinase suppresses endothelial cell proliferation by regulating cell-cycle progression.
Similar articles
-
p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.Oncogene. 1997 Oct;15(18):2169-77. doi: 10.1038/sj.onc.1201380. Oncogene. 1997. PMID: 9393975
-
Heterogeneity of the signal transduction pathways for VEGF-induced MAPKs activation in human vascular endothelial cells.J Cell Physiol. 2001 Aug;188(2):201-10. doi: 10.1002/jcp.1107. J Cell Physiol. 2001. PMID: 11424087
-
HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.Diabetologia. 2003 Jan;46(1):115-23. doi: 10.1007/s00125-002-0954-y. Epub 2002 Dec 6. Diabetologia. 2003. PMID: 12637990
-
[Fluid shear stress-mediated signal transduction in endothelial cells: temporal signaling events].Rinsho Ketsueki. 1998 Feb;39(2):124-5. Rinsho Ketsueki. 1998. PMID: 9545819 Review. Japanese. No abstract available.
-
Integrating the VEGF signals leading to actin-based motility in vascular endothelial cells.Trends Cardiovasc Med. 2000 Nov;10(8):321-7. doi: 10.1016/s1050-1738(01)00072-x. Trends Cardiovasc Med. 2000. PMID: 11369257 Review.
Cited by
-
The role of VEGF receptors in angiogenesis; complex partnerships.Cell Mol Life Sci. 2006 Mar;63(5):601-15. doi: 10.1007/s00018-005-5426-3. Cell Mol Life Sci. 2006. PMID: 16465447 Free PMC article. Review.
-
Modulatory effect of curcumin on survival of irradiated human intestinal microvascular endothelial cells: role of Akt/mTOR and NF-{kappa}B.Am J Physiol Gastrointest Liver Physiol. 2010 Jun;298(6):G865-77. doi: 10.1152/ajpgi.00339.2009. Epub 2010 Mar 18. Am J Physiol Gastrointest Liver Physiol. 2010. PMID: 20299603 Free PMC article.
-
Vascular smooth muscle cell proliferation in restenosis.Circ Cardiovasc Interv. 2011 Feb 1;4(1):104-11. doi: 10.1161/CIRCINTERVENTIONS.110.957332. Circ Cardiovasc Interv. 2011. PMID: 21325199 Free PMC article. Review. No abstract available.
-
Stromal cell-derived factor 1alpha (SDF-1alpha) induces gene-expression of early growth response-1 (Egr-1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation.Cell Prolif. 2003 Apr;36(2):75-86. doi: 10.1046/j.1365-2184.2003.00262.x. Cell Prolif. 2003. PMID: 12680875 Free PMC article.
-
A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance.Proc Natl Acad Sci U S A. 2005 May 10;102(19):6936-41. doi: 10.1073/pnas.0502256102. Epub 2005 Apr 28. Proc Natl Acad Sci U S A. 2005. PMID: 15860581 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous